EP 3271332 A1 20180124 - OXO-PYRIDINE-DERIVATIVES AS FACTOR XIA INHIBITORS FOR THE TREATMENT OF THROMBOSIS
Title (en)
OXO-PYRIDINE-DERIVATIVES AS FACTOR XIA INHIBITORS FOR THE TREATMENT OF THROMBOSIS
Title (de)
OXOPYRIDIN-DERIVATE ALS FAKTOR XIA HEMMER ZUR BEHANDLUNG VON THROMBOSE
Title (fr)
DÉRIVÉS D'OXOPYRIDINE COMME INHIBITEURS DU FACTEUR XIA POUR LE TRAITEMENT DE LA THROMBOSE
Publication
Application
Priority
- EP 15159829 A 20150319
- EP 2016055496 W 20160315
Abstract (en)
[origin: WO2016146606A1] The invention relates to substituted oxo-pyridine derivatives and methods for the production thereof, as well as to the use thereof in the production of medicaments for treating and/or preventing diseases, especially diseases of the cardiovascular system, preferably thrombotic or thromboembolic diseases, as well as oedemas, and also ophthalmological diseases.
IPC 8 full level
C07D 213/69 (2006.01); A61K 31/4418 (2006.01); A61P 7/00 (2006.01); A61P 9/00 (2006.01)
CPC (source: CN EP US)
A61K 9/0048 (2013.01 - US); A61K 9/0053 (2013.01 - US); A61K 9/2018 (2013.01 - US); A61K 9/2027 (2013.01 - US); A61K 9/2059 (2013.01 - US); A61K 9/2095 (2013.01 - US); A61P 7/02 (2017.12 - EP US); A61P 27/02 (2017.12 - EP US); C07D 213/69 (2013.01 - CN EP US)
Citation (search report)
See references of WO 2016146606A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2016146606 A1 20160922; CA 2979937 A1 20160922; CN 107428689 A 20171201; EP 3271332 A1 20180124; HK 1247615 A1 20180928; JP 2018509426 A 20180405; US 2019119213 A1 20190425
DOCDB simple family (application)
EP 2016055496 W 20160315; CA 2979937 A 20160315; CN 201680016726 A 20160315; EP 16709921 A 20160315; HK 18107027 A 20180530; JP 2017548389 A 20160315; US 201615557831 A 20160315